SEC 13F Intelligence

Signature Estate & Investment Advisors LLC / ALXN

Signature Estate & Investment Advisors LLC’s Alexion Pharmaceuticals Inc Position

Does Signature Estate & Investment Advisors LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 198.0K shares worth $26M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$26M
Q2 2019
Shares
198.0K
% of Portfolio
+1.98%
Quarters Held
2
position exited

Position History ALXN

Reported value by quarter
Q1 ’19: $22MQ1 ’19Q2 ’19: $26MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2019198.0K$26M+1.98%
Q1 2019165.8K$22M+1.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Signature Estate & Investment Advisors LLC’s full portfolio or all institutional holders of ALXN.